Topic:

Cancer Vaccines

Latest Headlines

Latest Headlines

Agenus inks Oncophage cancer vaccine deal with Russian company

Cancer vaccine developer Agenus has inked a licensing, development and manufacturing technology transfer agreement with Russian drug company NewVac. Under the deal, NewVac gets to manufacture, market...

Arginine could boost brain cancer vaccine success

University of Colorado Cancer Center researchers have discovered that arginine, an amino acid that's available over-the-counter, could re-energize cancer-fighting T-cells that are suppressed in...

Study: Vaccine developers should target deadliest cancers

Cancer vaccine developers are targeting cancers based on how many annual cases of those cancers occur, rather than the number of deaths they cause. That's according to research conducted at the...

Personalized cancer vax shows promise against glioblastomas in study

A personalized cancer vaccine has shown promise against glioblastomas, the most common malignant brain tumor. In a Phase I trial, 91 percent of patients receiving the vaccine--which was created using...